Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment

Cancer causes the second-highest rate of death world-wide. A major shortcoming inherent in most of anticancer drugs is their lack of tumor selectivity. Nanodrugs for cancer therapy administered intravenously escape renal clearance, are unable to penetrate through tight endothelial junctions of norma...

Descripción completa

Detalles Bibliográficos
Autores principales: Subhan, Md Abdus, Yalamarty, Satya Siva Kishan, Filipczak, Nina, Parveen, Farzana, Torchilin, Vladimir P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234032/
https://www.ncbi.nlm.nih.gov/pubmed/34207137
http://dx.doi.org/10.3390/jpm11060571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234032/
https://www.ncbi.nlm.nih.gov/pubmed/34207137
http://dx.doi.org/10.3390/jpm11060571

Ejemplares similares